Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,141,497 8.100% |
83,349 (+4.05%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Maquia Capital Acquisition Corporation MAQC |
Citadel Advisors LLC | 189 0.000% |
-1,256,785 (-99.98%) |
Filing History |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Energy Vault Holdings, Inc. NRGV |
Citadel Advisors LLC | 3,680 0.000% |
3,680 (New Position) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Vector Acquisition Corporation II VAQC |
Citadel Advisors LLC | 909 0.000% |
-2,913,539 (-99.97%) |
Filing History |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Waldencast plc WALD |
Citadel Advisors LLC | 9,597 0.000% |
9,597 (New Position) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | AfterNext HealthTech Acquisition Corp. AFTR |
Citadel Advisors LLC | 784 0.000% |
-1,881,735 (-99.96%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Colombier Acquisition Corp. CLBR |
Citadel Advisors LLC | 3,617 0.000% |
-1,240,230 (-99.71%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | DTRT Health Acquisition Corp. DTRT |
Citadel Advisors LLC | 2,429 0.100% |
-1,601,340 (-99.85%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Kensington Capital Acquisition Corp. V KCGI |
Citadel Advisors LLC | 3,656 0.000% |
-1,607,985 (-99.77%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Design Therapeutics, Inc. DSGN |
Citadel Advisors LLC | 2,668,230 4.800% |
-40,017 (-1.48%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Citadel Advisors LLC | 511,316 1.700% |
-823,557 (-61.70%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Priveterra Acquisition Corp. PMGM |
Citadel Advisors LLC | 1,658 0.000% |
-1,379,464 (-99.88%) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Citadel Advisors LLC | 4,057 0.000% |
-775,377 (-99.48%) |
Filing History |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Akili, Inc. AKLI |
Citadel Advisors LLC | 19,515 0.000% |
19,515 (New Position) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Independence Holdings Corp. ACQR |
Citadel Advisors LLC | 3,756,877 7.600% |
-400,258 (-9.63%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,747,391 7.400% |
12,322 (+0.71%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Bilander Acquisition Corp. TWCB |
Citadel Advisors LLC | 1,212,037 7.200% |
-73,522 (-5.72%) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Apollo Strategic Growth Capital II APGB |
Citadel Advisors LLC | 4,078,643 5.900% |
-51,113 (-1.24%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Calithera Biosciences, Inc. CALA |
Citadel Advisors LLC | 249,336 5.100% |
249,336 (New Position) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,981,324 5.700% |
116,524 (+4.07%) |
Filing History |